Dr John G Roth & Associates Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2 E Rolling Crossroads, Suite 55, Catonsville, MD 21228 Phone: 410-455-9660 Fax: 410-455-9665 |
Faezeh Bakhtiari-nejad, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2 E Rolling Xrds Ste 55, Catonsville, MD 21228 Phone: 410-455-9660 Fax: 410-455-9665 |
Podiatry Associates, P.a. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2 E Rolling Xrds Ste 55, Catonsville, MD 21228 Phone: 410-455-9660 |
Dr. Marc Neil Lipton, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 910 Frederick Rd, Catonsville, MD 21228 Phone: 410-644-1880 |
Hayden Lee Hoffler, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 910 Frederick Rd, Catonsville, MD 21228 Phone: 410-644-1880 Fax: 410-646-3623 |
Dr. John Galloway Roth, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 East Rolling Crossroads, Suite 55, Catonsville, MD 21228 Phone: 410-455-9660 Fax: 410-455-9665 |
News Archive
Even as New York Gov. Andrew Cuomo attempts to focus on trimming the state's Medicaid spending, the federal government charges the state with overbilling.
Catherine Ashton, High Representative of the Union for Foreign Affairs and Security Policy and Vice President of the European Commission, and Kristalina Georgieva, Commissioner for Humanitarian Aid and Civil Protection, will visit Haiti to evaluate the development of European humanitarian aid and assess future needs.
If we can set aside the political wrangling and focus on the benefits of the Affordable Care Act, what becomes obvious is its critically important impact on women's health. The fact is while women are the primary coordinators of health care for families and comprise the majority of U.S. health-care workers, they also put their own health-care needs behind those of their children. Cost is too often the reason.
Merck reported today that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained virologic response (SVR) rates in adult patients who previously failed treatment (treatment-failure; HCV RESPOND-2) and in adult patients who were new to treatment for chronic hepatitis C virus (HCV) genotype 1 compared to control, the primary objective of the studies.
› Verified 9 days ago